Predicting the failure of amyloid-beta vaccine.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  The Lancet

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 12044411
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.

  2000cited by this paper
• A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.

  2000cited by this paper
• Amyloid-beta junkies.

  2000cited by this paper
• Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

  1999cited by this paper

• Once upon a time, the Amyloid Cascade Hypothesis.

  2023cites this paper
• Detecting and tracking early neurodegeneration in familial Alzheimer's disease

  2018cites this paper
• Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer’s disease

  2018cites this paper
• Inconsistencies and Controversies Surrounding the Amyloid Hypothesis of Alzheimer's Disease

  2014cites this paper
• The end of Alzheimer's disease--from biochemical pharmacology to ecopsychosociology: a personal perspective.

  2014cites this paper
• Dissecting the molecular mechanism by which NH2htau and Aβ1-42 peptides impair mitochondrial ANT-1 in Alzheimer disease.

  2013cites this paper
• The Challenges of Cognitive Aging: Integrating Approaches from Science to Intergenerational Relationships

  2013cites this paper
• The Challenges of Cognitive Aging: Integrating Approaches from Neuroscience to Intergenerational Relationships

  2013cites this paper
• The role of iron as a mediator of oxidative stress in Alzheimer disease

  2012cites this paper
• Deciphering the physiology underlying the rapid clinical effects of perispinal etanercept in Alzheimer's disease.

  2012cites this paper
• Alzheimer's disease: redox dysregulation as a common denominator for diverse pathogenic mechanisms.

  2012cites this paper
• The concept of redox balance in Alzheimer's disease: Mark Anthony Smith 1965–2010

  2011cites this paper
• Uncertain Progress on the Fuzzy Boundaries of Alzheimer's Disease: Reading Between the Guidelines

  2011cites this paper
• Frontiers in Alzheimer’s disease therapeutics

  2011cites this paper
• Anti-Amnesic and Neuroprotective Actions of the Sigma-1 Receptor Agonist (-)-MR22 in Rats with Selective Cholinergic Lesion and Amyloid Infusion

  2011cites this paper
• Is TNF a Link between Aging-Related Reproductive Endocrine Dyscrasia and Alzheimer's Disease?

  2011cites this paper
• Novel therapeutics for Alzheimer's disease: an update.

  2010cites this paper
• A physiological role for amyloid-beta protein:enhancement of learning and memory.

  2010cites this paper
• Control of neuroinflammation as a therapeutic strategy for amyotrophic lateral sclerosis and other neurodegenerative disorders.

  2010cites this paper
• A Physiological Role for Amyloid-β Protein: Enhancement of Learning and Memory

  2010cites this paper
• Alzheimer's Disease is Incurable but Preventable

  2010cites this paper
• Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease

  2009cites this paper
• Current approaches in the treatment of Alzheimer's disease.

  2008cites this paper
• Pathology's new role: defining disease process and protective responses.

  2008cites this paper
• Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial.

  2008cites this paper
• Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees?

  2007cites this paper
• Iron: The Redox-active Center of Oxidative Stress in Alzheimer Disease

  2007cites this paper
• Treating the lesions, not the disease.

  2007cites this paper
• Amyloid-beta vaccination: testing the amyloid hypothesis?: heads we win, tails you lose!

  2006cites this paper
• Amyloid-Vaccination : Testing the Amyloid Hypothesis ?

  2006cites this paper
• Synaptic dysfunction and oxidative stress in Alzheimer’s disease: Emerging mechanisms

  2006cites this paper
• Antioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau.

  2006cites this paper
• Therapeutic options in Alzheimer’s disease

  2006cites this paper
• The Fallacy of Amyloid and Cognition in Alzheimer’s Disease

  2006cites this paper
• Antioxidant protection and neurodegenerative disease: The role of amyloid-β and tau

  2006cites this paper
• Amyloid β peptide binds a novel death‐inducing protein, AB‐DIP

  2005cites this paper
• Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective?

  2005cites this paper
• Antagonist of the Amylin Receptor Blocks β-Amyloid Toxicity in Rat Cholinergic Basal Forebrain Neurons

  2004cites this paper
• Microglia and Alzheimer's disease pathogenesis

  2004cites this paper
• Apolipoprotein Abeta: black sheep in a good family.

  2004cites this paper
• [Immunotherapy of Alzheimer's disease. Results of experimental investigations and treatment of perspectives].

  2004cites this paper
• Apolipoprotein Aβ: Black Sheep in a Good Family

  2004cites this paper
• Challenging the Amyloid Cascade Hypothesis: Senile Plaques and Amyloid‐β as Protective Adaptations to Alzheimer Disease

  2004cites this paper
• Intracerebroventricular passive immunization with anti‐Aβ antibody in Tg2576

  2003cites this paper
• New hope for Alzheimer disease vaccine

  2002cites this paper
• Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain.

  2002cites this paper
• Alzheimer's disease: how does it start?

  2002cites this paper
• For Personal Use. Only Reproduce with Permission the Lancet Publishing Group. Personal View Is Ad Neurodegenerative or Vascular? Is Ad Neurodegenerative? Is Alzheimer's Disease a Neurodegenerative or a Vascular Disorder? Data, Dogma, and Dialectics

  year unknowncites this paper